VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Associate Scientist, Discovery - Neuropsychiatry

Johnson & Johnson Innovative Medicine is focused on healthcare innovation to tackle complex diseases. They are seeking an Associate Scientist in Neuropsychiatry to contribute to research initiatives and support pipeline programs aimed at developing treatments for psychiatric diseases.

Former Chairman and CEO, Johnson & Johnson

Chairman of the Board and Chief Executive Officer

Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants

Johnson &amp; Johnson price target raised by $21 at Bernstein, here's why

Prostate Cancer Hormone Therapy Market to Reach US$ 79.89 Bn by 2032, Reports Persistence Market Research

Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Johnson & Johnson is a leader in healthcare innovation, seeking an Associate Scientist in Neuropsychiatry to join their team in San Diego, CA. The role involves conducting biochemical, cellular, and molecular biology experiments to advance research initiatives and support pipeline programs aimed at improving outcomes for patients suffering from psychiatric diseases.

Associate Scientist, Discovery   Neuropsychiatry

Associate Scientist, Discovery Neuropsychiatry in united states (1000+)

Associate Scientist, Discovery - Neuropsychiatry

Associate Scientist, Discovery - Neuropsychiatry